Explore the latest in cancer survivorship, including recent guidelines for surveillance of complications after cure in child and adult cancers.
A 52-year-old woman with type 2 diabetes and a history of breast cancer presents with blurry vision in her right eye and signs of intraretinal fluid. What would you do next?
This multicenter study investigates the risk factors, patterns, and outcomes of late recurrence after curative liver resection for hepatocellular carcinoma.
This survey study evaluates the presence of erectile dysfunction in men who had experienced cancer during childhood.
This cohort study uses Surveillance, Epidemiology, and End Results data to determine high- and low-risk periods for 68 cancer types that could define when survivorship care might best be overseen by oncologists and when to transition to primary care physicians.
This cross-sectional survey study of oropharyngeal cancer survivors investigates the association of late lower cranial neuropathy with severity of cancer treatment–related symptoms and general functional impairment.
In this article, the author discusses his struggles with hope and delusion in his personal experience with renal cell carcinoma.
This Viewpoint discusses the Centers for Disease Control and Prevention guidelines for prescribing opioids for chronic pain and how they may cause confusion for oncology clinicians.
This cohort analysis examines the association between self-reported exercise and change in exercise and mortality in adult survivors of childhood cancer.
This registry-based cohort study using data from the Surveillance, Epidemiology, and End Results (SEER) database investigates the risk of human papillomavirus (HPV)–associated second primary cancers among survivors of HPV-associated index cancers and tests the hypothesis that the risk of HPV-associated second primary cancer has increased over the last 4 decades.
This cross-sectional study comprehensively assesses chemotherapy-induced peripheral neuropathy in childhood cancer survivors to define disease burden and functional effect and aims to inform screening recommendations.
This population-based cohort study uses Danish Cancer Registry data to investigate the lifetime risk of endocrine late effects of cancer and cancer treatment, including pituitary and gonadal hypofunction, in patients diagnosed and treated as adolescents and young adults.
This nonrandomized, noncontrolled clinical trial evaluates the 6-month progression-free survival, tumor objective response, and overall survival rates in patients with gastrointestinal stromal tumors treated with dasatinib.
This population-based study analyzes cancer survivors’ ability to access and afford health care during implementation of the US Affordable Care Act using data from the 2010 to 2016 National Health Interview Survey.
This cohort study of patients with stage III colon cancer enrolled in the CALGB 89803/Alliance trial evaluated the association of survival rates with adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors.
This cohort study examines vision-targeted health-related quality of life as reported on the 25-item National Eye Institute Visual Field Questionnaire for overall and specific scale scores among adult survivors of retinoblastoma.
This phase 3 randomized clinical trial uses prespecified sensitivity analyses from 1717 men with chemotherapy-naive metastatic castration-resistant prostate cancer to assess the clinical relevance of the Prostate Cancer Working Group 2 definition of radiographic progression-free survival.
This cross-sectional survey study quantifies the prevalence of self-reported “job lock” in a sample of full-time employed childhood cancer survivors and their siblings participating in the Childhood Cancer Survivor Study.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: